{"disease":{"id":"fed-conditions","name":"fed conditions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07333742","title":"A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"LG Chem","has_results":false},{"nct_id":"NCT06103747","title":"Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet®","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Reseach Laboratory of Clinical and Experimental Pharmacology","has_results":false},{"nct_id":"NCT06073600","title":"Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet®","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Reseach Laboratory of Clinical and Experimental Pharmacology","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}